{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T04:44:28Z","timestamp":1744173868363},"reference-count":41,"publisher":"Elsevier BV","issue":"31-32","license":[{"start":{"date-parts":[[2004,10,1]],"date-time":"2004-10-01T00:00:00Z","timestamp":1096588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2004,10]]},"DOI":"10.1016\/j.vaccine.2004.06.013","type":"journal-article","created":{"date-parts":[[2004,7,27]],"date-time":"2004-07-27T21:39:35Z","timestamp":1090964375000},"page":"4173-4182","source":"Crossref","is-referenced-by-count":11,"title":["Humoral immune responses to a protective peptide-conjugate against measles after different prime-boost regimens"],"prefix":"10.1016","volume":"22","author":[{"given":"Mike M.","family":"P\u00fctz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wim","family":"Ammerlaan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00fcnther","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claude P.","family":"Muller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2004.06.013_bib1","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1093\/infdis\/161.6.1088","article-title":"Pattern of exposure and measles mortality in Senegal","volume":"161","author":"Garenne","year":"1990","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.vaccine.2004.06.013_bib2","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1016\/S0264-410X(00)00455-2","article-title":"Measles elimination: old and new challenges?","volume":"19","author":"Muller","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2004.06.013_bib3","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.2105\/AJPH.90.10.1521","article-title":"Measles eradication: is it in our future?","volume":"90","author":"Orenstein","year":"2000","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.vaccine.2004.06.013_bib4","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1586\/14760584.1.2.151","article-title":"Vaccination against measles: a neverending story","volume":"1","author":"Stittelaar","year":"2002","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.vaccine.2004.06.013_bib5","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0020-7519(03)00062-6","article-title":"Experimental vaccines against measles in a world of changing epidemiology","volume":"33","author":"P\u00fctz","year":"2003","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.vaccine.2004.06.013_bib6","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1016\/S0264-410X(99)00008-0","article-title":"A hemagglutinin-derived peptide-vaccine ignored by virus-neutralizing passive antibodies, protects against murine measles encephalitis","volume":"17","author":"El Kasmi","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2004.06.013_bib7","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1099\/0022-1317-81-3-729","article-title":"Neutralization of measles virus wild-type isolates after immunization with a synthetic peptide vaccine which is not recognized by neutralizing passive antibodies","volume":"81","author":"El Kasmi","year":"2000","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.vaccine.2004.06.013_bib8","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1046\/j.1432-1033.2003.03517.x","article-title":"Functional fine-mapping and molecular modeling of a conserved loop epitope of the measles virus hemagglutinin protein","volume":"270","author":"P\u00fctz","year":"2003","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.vaccine.2004.06.013_bib9","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S0264-410X(02)00576-5","article-title":"The rationale of a peptide-conjugate vaccine against measles","volume":"21","author":"P\u00fctz","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2004.06.013_bib10","series-title":"Haemophilus influenzae vaccines","author":"Ward","year":"1999"},{"key":"10.1016\/j.vaccine.2004.06.013_bib11","series-title":"Pneumococcal vaccine","author":"Fedson","year":"1999"},{"key":"10.1016\/j.vaccine.2004.06.013_bib12","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/eji.1830010103","article-title":"The carrier in the secondary response to hapten-protein conjugates. I.","volume":"1","author":"Mitchison","year":"1971","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.vaccine.2004.06.013_bib13","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/285664a0","article-title":"Carrier-priming leads to hapten-specific suppression","volume":"285","author":"Herzenberg","year":"1980","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2004.06.013_bib14","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.4049\/jimmunol.135.4.2319","article-title":"Carrier-induced epitopic suppression, a major issue for future synthetic vaccines","volume":"135","author":"Schutze","year":"1985","journal-title":"J. Immunol."},{"key":"10.1016\/j.vaccine.2004.06.013_bib15","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/S0140-6736(89)92033-3","article-title":"Effect of priming with carrier on response to conjugate vaccine","volume":"2","author":"Di John","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2004.06.013_bib16","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1128\/IAI.62.1.9-14.1994","article-title":"Opposite effects of actively and passively acquired immunity to the carrier on responses of human infants to a Haemophilus influenzae type b conjugate vaccine","volume":"62","author":"Barington","year":"1994","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vaccine.2004.06.013_bib17","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1084\/jem.152.2.361","article-title":"Preparation, characterization, and immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugates","volume":"152","author":"Schneerson","year":"1980","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.vaccine.2004.06.013_bib18","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1128\/IAI.39.1.233-238.1983","article-title":"Antibody responses to Haemophilus influenzae type b and diphtheria toxin induced by conjugates of oligosaccharides of the type b capsule with the non-toxic protein CRM197","volume":"39","author":"Anderson","year":"1983","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vaccine.2004.06.013_bib19","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.1016\/S0264-410X(99)00133-4","article-title":"Prior immunity to a carrier enhances antibody responses to hCG in recipients of an hCG-carrier conjugate vaccine","volume":"17","author":"Shah","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2004.06.013_bib20","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1128\/IAI.55.11.2658-2661.1987","article-title":"Enhanced epitopic response to a synthetic human malarial peptide by preimmunization with tetanus toxoid carrier","volume":"55","author":"Lise","year":"1987","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vaccine.2004.06.013_bib21","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.1128\/IAI.59.10.3504-3510.1991","article-title":"Effect of carrier priming on immunogenicity of saccharide-protein conjugate vaccines","volume":"59","author":"Peeters","year":"1991","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vaccine.2004.06.013_bib22","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/00006454-199606000-00011","article-title":"Passively acquired anti-tetanus and anti-Haemophilus antibodies and the response to Haemophilus influenzae type b-tetanus toxoid conjugate vaccine in infancy","volume":"15","author":"Kurikka","year":"1996","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.vaccine.2004.06.013_bib23","doi-asserted-by":"crossref","first-page":"4138","DOI":"10.1002\/(SICI)1521-4141(199812)28:12<4138::AID-IMMU4138>3.0.CO;2-L","article-title":"Influence of maternal antibodies on vaccine responses: inhibition of antibody but not T cell responses allows successful early prime-boost strategies in mice","volume":"28","author":"Siegrist","year":"1998","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.vaccine.2004.06.013_bib24","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/S0264-410X(98)00100-5","article-title":"Determinants of infant responses to vaccines in presence of maternal antibodies","volume":"16","author":"Siegrist","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2004.06.013_bib25","doi-asserted-by":"crossref","first-page":"394","DOI":"10.4049\/jimmunol.142.2.394","article-title":"Delineation of several DR-restricted tetanus toxin T cell epitopes","volume":"142","author":"Demotz","year":"1989","journal-title":"J. Immunol."},{"key":"10.1016\/j.vaccine.2004.06.013_bib26","unstructured":"Efstratiou A, Maple PAC. Laboratory Diagnosis of Diphtheria. Copenhagen: The Expanded Program on Immunization in the European Region of WHO, 1994."},{"key":"10.1016\/j.vaccine.2004.06.013_bib27","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1001\/jama.272.14.1116","article-title":"Effect of carrier protein priming on antibody responses to Haemophilus influenzae type b conjugate vaccines in infants","volume":"272","author":"Granoff","year":"1994","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.vaccine.2004.06.013_bib28","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/S0264-410X(96)00025-4","article-title":"Priming with diphtheria-tetanus-pertussis vaccine enhances the response to the Haemophilus influenzae type b tetanus conjugate vaccine in infancy","volume":"14","author":"Kurikka","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2004.06.013_bib29","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1084\/jem.129.6.1131","article-title":"The requirement of more than one antigenic determinant for immunogenicity","volume":"129","author":"Rajewsky","year":"1969","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.vaccine.2004.06.013_bib30","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/0264-410X(92)90046-M","article-title":"Immunogenicity of a Streptococcus pneumoniae type 4 polysaccharide--protein conjugate vaccine is decreased by admixture of high doses of free saccharide","volume":"10","author":"Peeters","year":"1992","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2004.06.013_bib31","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/0140-6736(92)90336-2","article-title":"Immunogenicity of combined diphtheria, tetanus, and pertussis vaccine given at 2, 3, and 4 months versus 3, 5, and 9 months of age","volume":"339","author":"Booy","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2004.06.013_bib32","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1093\/infdis\/165.5.977","article-title":"Maternal antibodies partly inhibit an active antibody response to routine tetanus toxoid immunization in infants","volume":"165","author":"Sarvas","year":"1992","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.vaccine.2004.06.013_bib33","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1128\/IAI.61.2.432-438.1993","article-title":"Non-epitope-specific suppression of the antibody response to Haemophilus influenzae type b conjugate vaccines by preimmunization with vaccine components","volume":"61","author":"Barington","year":"1993","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vaccine.2004.06.013_bib34","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1097\/00006454-200206000-00013","article-title":"Immune response to octavalent diphtheria- and tetanus-conjugated pneumococcal vaccines is serotype- and carrier-specific: the choice for a mixed carrier vaccine","volume":"21","author":"Sigurdardottir","year":"2002","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.vaccine.2004.06.013_bib35","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0022-3476(05)81786-X","article-title":"Efficacy and safety of a Haemophilus influenzae type b capsular polysaccharide-tetanus protein conjugate vaccine","volume":"121","author":"Fritzell","year":"1992","journal-title":"J. Pediatr."},{"key":"10.1016\/j.vaccine.2004.06.013_bib36","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1056\/NEJM199011153232004","article-title":"A randomized, prospective field trial of a conjugate vaccine in the protection of infants and young children against invasive Haemophilus influenzae type b disease","volume":"323","author":"Eskola","year":"1990","journal-title":"N. Eng. J. Med."},{"key":"10.1016\/j.vaccine.2004.06.013_bib37","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1016\/S0140-6736(99)04377-9","article-title":"Combined vaccination of Haemophilus influenzae type b conjugate and diphtheria-tetanus-pertussis containing acellular pertussis","volume":"354","author":"Eskola","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2004.06.013_bib38","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0022-3476(96)70364-5","article-title":"Comparison of five different vaccination schedules with Haemophilus influenzae type b-tetanus toxoid conjugate vaccine","volume":"128","author":"Kurikka","year":"1996","journal-title":"J. Pediatr."},{"key":"10.1016\/j.vaccine.2004.06.013_bib39","first-page":"599","article-title":"Bypass of carrier-induced epitope-specific suppression using a T-helper epitope","volume":"76","author":"Sad","year":"1992","journal-title":"Immunology"},{"key":"10.1016\/j.vaccine.2004.06.013_bib40","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1002\/eji.1830251226","article-title":"Carrier-induced epitope-specific regulation and its bypass in a protein-protein conjugate","volume":"25","author":"Kaliyaperumal","year":"1995","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.vaccine.2004.06.013_bib41","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1046\/j.1365-2249.2000.01351.x","article-title":"Humoral hyporesponsiveness to a conjugate contraceptive vaccine and its bypass by diverse carriers using permissible adjuvant","volume":"122","author":"Mandokhot","year":"2000","journal-title":"Clin. Exp. Immunol."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X04004797?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X04004797?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T03:00:39Z","timestamp":1682737239000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X04004797"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,10]]},"references-count":41,"journal-issue":{"issue":"31-32","published-print":{"date-parts":[[2004,10]]}},"alternative-id":["S0264410X04004797"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2004.06.013","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2004,10]]}}}